implicated in the progression of human cancers. We found that the binding cleft of the
Dishevelled PDZ domain is more flexible than those of canonical PDZ domains and enables
recognition of both C-terminal and internal peptides. These peptide ligands inhibit Wnt/β-
catenin signaling in cells, showing that Dishevelled PDZ domains are potential targets for
small-molecule cancer therapeutics.